Literature DB >> 26563280

Pharmacokinetics of sarafloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio.

Xingxing Fang1, Jianguo Zhou1, Xiuhong Liu2.   

Abstract

The pharmacokinetic properties of sarafloxacin were investigated after single intravenous (i.v.) and oral (p.o.) administration of 10 mg/kg body weight (b.w.) in allogynogenetic silver crucian carp at 24-26 °C. The plasma concentrations of sarafloxacin were determined by high-performance liquid chromatography. After i.v. administration, the plasma concentration-time data were described by an open two-compartment model. The elimination half-life (T(1/2β)) was estimated to be 22.58 h. The volume of distribution, V(d(area)), was estimated to be 5.95 L/kg, indicating good tissue penetration of sarafloxacin in the fish. Area under the concentration-time curve (AUC) and total body clearance of sarafloxacin were 56.86 µg·h/mL and 0.18 L/h/kg, respectively. Following p.o. administration, the maximum plasma concentration (C(max)), T(1/2β), and AUC of sarafloxacin were 0.79 µg/mL, 46.68 h, and 16.58 µg·h/mL, respectively. Absorption of the drug was not good with a bioavailability (F) of 29.15%. Based on a minimum inhibitory concentration (MIC) of 0.00625 to 0.045 μg/mL for susceptible strains, sarafloxacin p.o. administration at a dose 10 mg/kg could be efficacious against common pathogenic bacteria of fish.

Entities:  

Keywords:  Allogynogenetic silver crucian carp; Intravenous; Oral; Pharmacokinetics; Plasma; Sarafloxacin

Mesh:

Substances:

Year:  2015        PMID: 26563280     DOI: 10.1007/s10695-015-0141-y

Source DB:  PubMed          Journal:  Fish Physiol Biochem        ISSN: 0920-1742            Impact factor:   2.794


  10 in total

1.  Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection.

Authors:  George G. Zhanel
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Pharmacokinetics of enrofloxacin in lactating sheep.

Authors:  A Haritova; L Lashev; D Pashov
Journal:  Res Vet Sci       Date:  2003-06       Impact factor: 2.534

3.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

4.  Pharmacokinetics of enrofloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio.

Authors:  X Fang; X Liu; W Liu; C Lu
Journal:  J Vet Pharmacol Ther       Date:  2011-09-14       Impact factor: 1.786

5.  Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in the Korean catfish (Silurus asotus).

Authors:  B-K Park; J-H Lim; M-S Kim; H-I Yun
Journal:  J Vet Pharmacol Ther       Date:  2006-02       Impact factor: 1.786

Review 6.  Drugs in salmonid aquaculture--a review.

Authors:  J F Burka; K L Hammell; T E Horsberg; G R Johnson; D J Rainnie; D J Speare
Journal:  J Vet Pharmacol Ther       Date:  1997-10       Impact factor: 1.786

7.  Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla).

Authors:  S P Ho; C F Cheng; W S Wang
Journal:  J Vet Med Sci       Date:  1999-05       Impact factor: 1.267

8.  Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.

Authors:  G L Drusano; D E Johnson; M Rosen; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss).

Authors:  P R Bowser; G A Wooster; J St Leger; J G Babish
Journal:  J Vet Pharmacol Ther       Date:  1992-03       Impact factor: 1.786

10.  Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 degrees C.

Authors:  B Martinsen; T E Horsberg
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.